China's Envision Energy has agreed to deliver 200GWh of green power annually to five global pharmaceuticals companies to help decarbonise healthcare systems.
Envision announced today that it has signed a three-year supply agreement with UK-Swedish company AstraZeneca, Denmark’s Novo Nordisk and the Swiss trio of Novartis, Lonza and Roche.
Envision will supply the power to the companies for their operations in China, sourcing it both from its own operations and from the wholesale markets, the developer confirmed to Recharge.
